Upstream process characterization
Validate your upstream biologics processes with our upstream process characterization CDMO solutions.
What is upstream process characterization?
Upstream process characterization is a process where cell lines, culture media and conditions are characterized. At Enzene Biosciences, we use upstream process characterization to optimize manufacturing conditions to ensure the efficient, high-quality and cost-effective production of your biologics.
Our upstream process characterization solutions help to enable the consistent production of high-quality biologics, reduce process variability and facilitate regulatory compliance. Troubleshooting and process optimization are also improved, leading to improved efficiency and reduced costs.
What modalities can we handle with our upstream process characterization?
- Monoclonal antibodies (mAbs)
- Therapeutic recombinant proteins
- Recombinant enzymes
- Conjugated proteins
- Bispecific proteins
- Fusion proteins
- Plasmid DNA (pDNA)
Understanding our upstream process characterization solutions
We can characterize both fed-batch and continuous upstream processes including:
- Cell line characterization
- Culture medium characterization
- Cell culture and bioreactor conditions
Why partner with Enzene for upstream process characterization?
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars, along with our upstream process characterization solutions, are designed to cater to your project’s every need.
Related case studies
Latest resources
Join the CDMO revolution
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.